Tetrahydrocannabinolic acid (THCA) is the non-psychoactive cannabinoid within the Cannabis plant from which tetrahydrocannabinol (THC) is derived. THCA does not cause the sensation of a high and shows therapeutic promise through its anti-inflammatory, antispasmodic, and neuroprotective properties.
THCA works through the endocannabinoid system to exert it’s health-promoting effects.
Protects the brain
- Promote the optimal regulation of brain inflammation.
- Support a healthier response to inflammatory damage.
Defends against cancer
Due to these numerous health benefits, the food industry has also taken advantage of THCA. Cannabis tea has become increasingly popular with THCA being one of the most abundant cannabinoids present within the Cannabis plant.
Rare cannabinoids, such as THCA, exist in minimal quantities in cannabis plants. This makes their extraction and purification inefficient, costly and environmentally taxing. THCA is extracted from cannabis, which requires significant regulatory oversight and can produce inconsistent yields prone to contamination from pests, mold, and pesticides. Due to these limitations, the chemical synthesis of THCA has become the leading production method. However, chemical synthesis produces artificial forms of THCA, which can have undesirable side effects.
The production of THCA through biosynthesis offers a way to reduce the environmental footprint, decrease the time of production, circumvent regulatory oversight, and produce high-quality cannabinoids. Biosynthesis, a process that has been used for several years in multiple industries, revolutionizes the production of cannabinoids by reducing the cost of their production by 70-90%.
Biomedican uses a unique proprietary yeast, which undergoes the natural metabolic process of fermentation, to produce THCA that is identical to its counterparts in nature. The advantage of this natural process is that it is 100% pure, reliable, and does not come with the undesirable side effects of chemical synthesis.